| 000 | 01646 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514051508.0 | ||
| 264 | 0 | _c20021213 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/41.11.1303 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamprecht, P | |
| 245 | 0 | 0 |
_aEffectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cNov 2002 |
||
| 300 |
_a1303-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGranulomatosis with Polyangiitis _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSampling Studies |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _aVoswinkel, J | |
| 700 | 1 | _aLilienthal, T | |
| 700 | 1 | _aNolle, B | |
| 700 | 1 | _aHeller, M | |
| 700 | 1 | _aGross, W L | |
| 700 | 1 | _aGause, A | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 41 _gno. 11 _gp. 1303-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/41.11.1303 _zAvailable from publisher's website |
| 999 |
_c12229546 _d12229546 |
||